|
GSEC expression profile based on
|
*
Please note that low number(<10) of normal samples considered.
CHOL : Cholangiocarcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.65440014878021E-08
|
|
*
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.96176830826178E-05 |
| Normal-vs-Stage2 |
2.610675E-03 |
| Normal-vs-Stage3 |
NA |
| Normal-vs-Stage4 |
5.938359E-03 |
| Stage1-vs-Stage2 |
2.865962E-02 |
| Stage1-vs-Stage3 |
NA |
| Stage1-vs-Stage4 |
3.599181E-01 |
| Stage2-vs-Stage3 |
NA |
| Stage2-vs-Stage4 |
2.332066E-01 |
| Stage3-vs-Stage4 |
NA |
|
|
*
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.92016274262535E-07 |
| Normal-vs-AfricanAmerican |
9.065568E-02 |
| Normal-vs-Asian |
6.398534E-02 |
| Caucasian-vs-AfricanAmerican |
1.205299E-01 |
| Caucasian-vs-Asian |
6.737190E-01 |
| AfricanAmerican-vs-Asian |
4.653294E-01 |
|
|
*
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.454093E-04 |
| Normal-vs-Female |
1.93606366053492E-05 |
| Male-vs-Female |
7.020518E-02 |
|
|
*
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.718395E-01 |
| Normal-vs-Age(41-60Yrs) |
8.268693E-03 |
| Normal-vs-Age(61-80Yrs) |
8.36469590493605E-07 |
| Normal-vs-Age(81-100Yrs) |
5.045872E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.301385E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.800159E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.335938E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.606517E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.052415E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.887710E-01 |
|
|
*
Please note that low number(<10) of normal samples considered.
| Descriptions |
| NormalWeight | BMI is >=18.5 and <25 |
ExtremeWeight | BMI is >=25 and <30 |
| Obese | BMI is >=30 and <40 |
ExtremeObese | BMI is >=40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-NormalWeight |
3.640111E-04 |
| Normal-vs-ExtremeWeight |
1.342176E-03 |
| Normal-vs-Obese |
1.379941E-03 |
| Normal-vs-ExtremeObese |
NA |
| NormalWeight-vs-ExtremeWeight |
4.629546E-01 |
| NormalWeight-vs-Obese |
2.852425E-01 |
| NormalWeight-vs-ExtremeObese |
NA |
| ExtremeWeight-vs-Obese |
8.421829E-01 |
| ExtremeWeight-vs-ExtremeObese |
NA |
| Obese-vs-ExtremeObese |
NA |
|
|
*
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade1 |
NA |
| Normal-vs-Grade2 |
1.18007984029853E-05 |
| Normal-vs-Grade3 |
1.526402E-04 |
| Normal-vs-Grade4 |
5.042758E-01 |
| Grade1-vs-Grade2 |
NA |
| Grade1-vs-Grade3 |
NA |
| Grade1-vs-Grade4 |
NA |
| Grade2-vs-Grade3 |
1.512124E-01 |
| Grade2-vs-Grade4 |
8.473741E-01 |
| Grade3-vs-Grade4 |
9.122027E-01 |
|
|
